The effect of rivaroxaban exposure and clinical risk factors on efficacy and safety outcomes in patients with acute coronary syndromesLiping Zhang,Xiaoyu Yan,Stefan Willmann,Dirk Garmann,Partha Nandy,Amarnath Sharma,Anne Hermanowski-Vosatka,Scott D. Berkowitz,Theodore Spiro,Alexander Solms,Keith A. A. Fox,Jeffrey I. Weitz,Stephan Schmidt,Gary PetersJOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS（2017）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
